SPACs: Special Purpose Acquisition Companies

By Dr. David Edward Marcinko MBA MEd

***

***

A Special Purpose Acquisition Company (SPAC) is a corporate entity created solely to raise capital through an initial public offering (IPO) with the intention of merging with or acquiring an existing private company. Unlike traditional firms, SPACs have no commercial operations at the time of their IPO. They exist as shell companies, holding investor funds in trust until a suitable target is identified. This unique structure has earned them the nickname “blank check companies.”

How SPACs Work

The lifecycle of a SPAC typically unfolds in three stages:

  • Formation and IPO: Sponsors—often experienced investors or industry executives—form the SPAC and take it public, raising funds from investors.
  • Target Search: The SPAC has a limited time frame, usually 18–24 months, to identify and negotiate with a private company to merge with.
  • De-SPAC Transaction: Once a merger is completed, the private company effectively becomes public, bypassing the traditional IPO process.

This process allows private firms to access public markets more quickly and with fewer regulatory hurdles compared to conventional IPOs.

Advantages of SPACs

SPACs gained traction because they offered several benefits:

  • Speed and Certainty: Traditional IPOs can be lengthy and uncertain, while SPACs provide a faster route to public markets.
  • Flexibility in Valuation: Unlike IPOs, SPACs can negotiate valuations directly with target companies.
  • Access to Expertise: Sponsors often bring industry knowledge and networks that can help the acquired company grow.
  • Investor Opportunity: Investors can participate early, with the option to redeem shares if they dislike the proposed merger.

Risks and Criticisms

Despite their appeal, SPACs are not without controversy:

  • Sponsor Incentives: Sponsors typically receive a significant stake (often 20%) at a low cost, which can misalign their interests with ordinary investors.
  • Uncertain Targets: Investors commit funds without knowing which company will be acquired, creating risk.
  • Performance Concerns: Studies show that many SPACs underperform after completing mergers, with share prices often declining.
  • Regulatory Scrutiny: Authorities have warned investors to carefully evaluate SPACs, especially regarding projections of future performance, which are less restricted than in IPOs.

Historical Context and Trends

SPACs first appeared in the 1990s but remained niche until the early 2020s, when they experienced a boom. In 2020 and 2021, hundreds of SPAC IPOs raised billions of dollars, fueled by market liquidity and investor enthusiasm. High-profile deals, such as DraftKings and Virgin Galactic, brought attention to the model. However, by the mid-2020s, enthusiasm cooled due to poor post-merger performance and tighter regulations.

Conclusion

SPACs represent a fascinating innovation in financial markets, offering an alternative to traditional IPOs. Their advantages in speed, flexibility, and access to capital made them attractive during periods of market optimism. Yet, their risks—misaligned incentives, uncertain outcomes, and regulatory challenges—have tempered investor enthusiasm. While SPACs are unlikely to disappear entirely, their future will depend on whether they can evolve into a more transparent and sustainable mechanism for taking companies public.

COMMENTS APPRECIATED

EDUCATION: Books

SPEAKING: Dr. Marcinko will be speaking and lecturing, signing and opining, teaching and preaching, storming and performing at many locations throughout the USA this year! His tour of witty and serious pontifications may be scheduled on a planned or ad-hoc basis; for public or private meetings and gatherings; formally, informally, or over lunch or dinner. All medical societies, financial advisory firms or Broker-Dealers are encouraged to submit an RFP for speaking engagements: CONTACT: Ann Miller RN MHA at MarcinkoAdvisors@outlook.com -OR- http://www.MarcinkoAssociates.com

Like, Refer and Subscribe

***

***

MARKETS: Wall Street

By AI

***

***

Wall Street is stable right now as the technology trade has come roaring back.

The S&P 500 climbed above 6,000 points for the first time since February, while all three indexes posted their fifth winning week in the last seven. The S&P is now just over 2% from its all-time high.

Meanwhile, recent IPOs are party rocking, especially the stablecoin issuer Circle that went public last Thursday.

IPO: https://medicalexecutivepost.com/2025/03/02/ipo-road-show-with-pros-and-cons/

COMMENTS APPRECIATED

Like and Refer

***

***

Investing “Tips” on Initial Public Offerings [IPOs]

Some Investing Tips and Pearls

By Dr. David Marcinko MBA MEd CMP

http://www.MarcinkoAssociates.com

Initial public offerings, known as IPOs, tend to attract a lot of investor interest – especially when the company is well-known. However, that excitement isn’t always matched by investment returns.

“Tips and Pearls”

So, here are some tips to consider before you decide to invest in an IPO:

• Don’t let the excitement surrounding an IPO cloud your judgment. Too often, there is little financial information about the companies themselves, and many are not profitable. This can translate into extremely volatile stock prices.

• While an IPO’s stock price tends to rise on the day it begins trading, investors who bought shares at the end of the first day haven’t always fared well. The stocks have often fallen below the closing first-day price after six months.

High volatility and a falling stock price are not generally a recipe for attractive investor returns.

So what steps should you take if you’re still interested in an IPO?

1. Understand that the opening price will likely be different from the official IPO price. New issues can experience extreme volatility in the first few hours and days of trading in the secondary market. When the company’s stock opens for secondary trading and becomes more widely available, the price can be significantly different from the IPO price set by the security underwriters. In addition, new issues often do not begin trading the moment the market opens.

2. Use a limit order. This can help you avoid paying more for the stock than you intended. Once you understand the risks of purchasing a stock during its first public trading days, work with your financial advisor to determine the highest price you’re willing to pay for the stock, and then set that amount as your limit.

3. Remember that an IPO must be priced before an order can be accepted. For example, Edward Jones typically does not accept orders until after an IPO has been priced, which is usually the morning the new issue begins trading. In addition, your financial advisor is not permitted to accept market orders for any IPO prior to its trading in the secondary market.

***

https://www.amazon.com/Comprehensive-Financial-Planning-Strategies-Advisors/dp/1482240289/ref=sr_1_1?ie=UTF8&qid=1418580820&sr=8-1&keywords=david+marcinko

***

Assessment

Remember to always do your homework before deciding on any investment, including an IPO. This includes working with your financial advisor or accountant to determine whether the investment is suitable for your portfolio.

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements.

Book Marcinko: https://medicalexecutivepost.com/dr-david-marcinkos-bookings/

Subscribe: MEDICAL EXECUTIVE POST for curated news, essays, opinions and analysis from the public health, economics, finance, marketing, IT, business and policy management ecosystem.

***

Risk Management, Liability Insurance, and Asset Protection Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners™8Comprehensive Financial Planning Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners™

***

DAILY UPDATE: D-Day, Digital Health, Stock Companies as Markets Zoom Up!

MEDICAL EXECUTIVE-POST TODAY’S NEWSLETTER BRIEFING

***

Essays, Opinions and Curated News in Health Economics, Investing, Business, Management and Financial Planning for Physician Entrepreneurs and their Savvy Advisors and Consultants

Serving Almost One Million Doctors, Financial Advisors and Medical Management Consultants Daily

A Partner of the Institute of Medical Business Advisors , Inc.

http://www.MedicalBusinessAdvisors.com

SPONSORED BY: Marcinko & Associates, Inc.

***

http://www.MarcinkoAssociates.com

Daily Update Provided By Staff Reporters Since 2007.
How May We Serve You?
© Copyright Institute of Medical Business Advisors, Inc. All rights reserved. 20224

REFER A COLLEAGUE: MarcinkoAdvisors@msn.com

SPONSORSHIPS AVAILABLE: https://medicalexecutivepost.com/sponsors/

ADVERTISE ON THE ME-P: https://tinyurl.com/ytb5955z

***

Today is the 80th anniversary of D-Day: More than 60 World War II veterans flew to Paris over the weekend to take part in what organizers believe could be the final major WWII commemoration involving living veterans. American veterans will be joined by President Joe Biden and other heads of state in Normandy.

CITE: https://www.r2library.com/Resource

The digital health market has had a tough year, with no IPOs in all of 2023. Comparatively, the industry saw roughly 20 public exits in 2021. The recent slowdown in the broader IPO market is linked to several trends, including high interest rates and some high-profile bankruptcies, according to Adriana Krasniansky, head of research at digital health strategy group and venture fund Rock Health’s advisory arm.

Here’s where the major benchmarks ended:

  • The S&P 500 index rose 62.69 points (1.2%) to 5,354.03; the Dow Jones Industrial Average® ($DJI) gained 96.04 points (0.3%) to 38,807.33; the NASDAQ Composite rallied 330.86 points (2.0%) to 17,187.90.
  • The 10-year Treasury note yield (TNX) fell more than 5 basis points to 4.283%, its lowest level since April 1.
  • The CBOE Volatility Index® (VIX) declined 0.53 to 12.63.

What’s up

  • Nvidia only rose 5.16% today, but it was enough to surpass Apple’s market cap, making the high-flying semiconductor stock the second most valuable public company in the US.
  • Crowdstrike rose 11.98% today after reporting better than expected fiscal first quarter earnings yesterday afternoon.
  • Guidewire Software rose 17.63% today after its beat & raise quarterly report late yesterday.
  • Stitch Fix rose 29.40% after a red-hot earnings report, completely turning around the stock’s slow slide downward this year.
  • SweetGreen popped 12.76% this afternoon after revealing that its new automated kitchens can actually save on costs and cut time for orders in the long run.

What’s down

CITE: https://tinyurl.com/2h47urt5

In case you needed more proof that we’re living in the strangest timeline: Morgan Stanley, which owns E*Trade, is contemplating kicking stock influencer Roaring Kitty off the platform. It’s concerned he manipulated GameStop stocks by…posting a meme on X. (the Wall Street Journal)

CITE: https://tinyurl.com/tj8smmes

COMMENTS APPRECIATED

PLEASE SUBSCRIBE: MarcinkoAdvisors@msn.com

Thank You

***

***

***

***

EDUCATIONAL TEXTBOOKS: https://tinyurl.com/4zdxuuwf

***

DAILY UPDATE: Reddit IPO

By Staff Reporters

***

***

Stat: $748 million. That’s how much Reddit plans to raise ahead of its upcoming IPO, where the company is seeking an approximate $6.5 billion valuation. After a couple of rocky IPO years, investors have been hotly anticipating Reddit’s IPO, which would mark the first social media IPO since Pinterest’s in 2019.(CNBC)

But, The FTC is investigating Reddit’s policies of licensing data for training AI, the company said Friday as it gears up for an IPO.

CITE: https://www.r2library.com/Resource

COMMENTS APPRECIATED

Thank You

HAPPY ST. URHO’S DAY

***

***

DAILY UPDATE: Stock Markets Rally and IPOs

By Staff Reporters

***

SPONSOR: http://www.MarcinkoAssociates.com

***

As we reported, the S&P 500 had its best day of the year on Friday as stocks kept their November rally rolling right into December. Pfizer, however, fell to its lowest since March 2020 after announcing that it’s pulling the plug on its experimental twice-a-day weight loss pill because it caused too many negative side effects even as pharmaceutical companies are rushing to serve the growing weight loss market.

***

And, Panera Bread filed IPO paperwork, the Financial Times reported. And it’s not the only household name that’s anticipated to hit brokerage apps next year as more companies are once again considering going public. The past two years have been an IPO stale mate as rising interest rates led to a tepid market for newcomers. Last year, Panera itself aborted a public listing it was planning via a special purpose acquisition company [SPAC] due to harsh market conditions.

CITE: https://medicalexecutivepost.com/2022/06/13/spac-v-direct-listing-v-ipo/

But, things might be different in 2024. Fast-fashion behemoth Shein also recently filed paperwork for what could be a blockbuster IPO that raises as much as $90 billion, per Bloomberg. The publication says that more companies are rumored to be thinking about joining the potential IPO bonanza. For example:

  • Kim Kardashian might list her $4 billion undergarment brand, Skims.
  • Reddit is supposedly flirting with the idea of going public. It would be the first major social media IPO in years, and it’s been in the offing since last year, when Reddit was valued at $15 billion.

However, all IPOs have not done well:

  • The Birkenstock and Instacart IPOs fell short of expectations according to investment data from Dealogic
  • Three out of four companies that IPOed this year were trading below their offer prices as of the middle of last month.
  • Companies debuting on the public markets raised a meager $20 billion so far this year, a slight rebound from 2022 but a ~90% decline from 2021.

CITE: https://www.r2library.com/Resource

COMMENTS APPRECIATED

Refer a Colleague: MarcinkoAdvisors@msn.com

Your referral Count: 0

Thank You

***

***

NYSE: Game-On for IPOs

By Staff Reporters

SPONSOR: http://www.CERTIFIEDMEDICALPLANNER.org

***

***

DEFINITION: An initial public offering (IPO) or stock launch is a public offering in which shares of a company are sold to institutional investors and usually also to retail (individual) investors An IPO is typically underwritten by one or more investment banks who also arrange for the shares to be listed on one or more stock exchanges. Through this process, colloquially known as floating, or going public, a privately held company is transformed into a public company. Initial public offerings can be used to raise new equity capital for companies, to monetize the investments of private shareholders such as company founders or private equity investors, and to enable easy trading of existing holdings or future capital raising by becoming publicly traded.

CITE: https://www.r2library.com/Resource

After the IPO, shares are traded freely in the open market at what is known as the free float. Stock exchanges stipulate a minimum free float both in absolute terms (the total value as determined by the share price multiplied by the number of shares sold to the public) and as a proportion of the total share capital (i.e., the number of shares sold to the public divided by the total shares outstanding). Although IPO offers many benefits, there are also significant costs involved, chiefly those associated with the process such as banking and legal fees, and the ongoing requirement to disclose important and sometimes sensitive information.

Cite: Wikipedia

***

Now, the NYSE is the world’s largest stock exchange, and for good reason. From thrilling new entries into the public market to a relentless commitment to transformative tech, the NYSE is constantly upping their game.

Related: https://medicalexecutivepost.com/2023/09/19/ipos-more-caution-ahead/

***

***

COMMENTS APPRECIATED

Join Us

***

“Deep Tech” Entrepreneurial Start-Ups

Entrepreneurs

By Dr. Jeffery Funk

All 12 Ex-Unicorn Deep Tech startups are unprofitable and another 20 privately-held #Unicorns appear to be far from profitability.

These 32 include biotech/health (12), AI/Big Data (8), sensors/AVs (4), wearables (3), satellites/space (2), and one for 3D printing, storage, and fuel cells. Of ex-Unicorns, 10 have losses greater than 30% of revenues.

Why are these #deeptech #startups so unprofitable?

My conclusion is fewer #breakthrough #technologies are coming out than decades before and ones coming out are taking longer to successfully commercialize. #AI/#BigData, sensors/#AVs, wearables, satellites, 3D printing, and fuel cells have all been over-hyped, their costs and performance are still disappointing, and their diffusion continues to be slow.

Overall, a successful example of a breakthrough #technology is hard to find since iPhone was introduced in 2007, other than OLEDs and solar cells. Yes AI, #EVs, drones, VR, AR, and IoT are diffusing and thus an analysis in 10 years might come to different conclusions, but for 2010s, there was little to commercialize. #innovation #ipo #ipos #venturecapital #vcs #vc https://lnkd.in/gThUWFR

***

***

UPDATE: https://www.seedtable.com/startups-deeptech

***

COMMENTS APPRECIATED

Thank You

***

“Deep Tech” Entrepreneurial Start-Ups

Entrepreneurs

By Dr. Jeffery Funk

All 12 Ex-Unicorn Deep Tech startups are unprofitable and another 20 privately-held #Unicorns appear to be far from profitability.

These 32 include biotech/health (12), AI/Big Data (8), sensors/AVs (4), wearables (3), satellites/space (2), and one for 3D printing, storage, and fuel cells. Of ex-Unicorns, 10 have losses greater than 30% of revenues.

Why are these #deeptech #startups so unprofitable?

My conclusion is fewer #breakthrough #technologies are coming out than decades before and ones coming out are taking longer to successfully commercialize. #AI/#BigData, sensors/#AVs, wearables, satellites, 3D printing, and fuel cells have all been over-hyped, their costs and performance are still disappointing, and their diffusion continues to be slow.

Overall, a successful example of a breakthrough #technology is hard to find since iPhone was introduced in 2007, other than OLEDs and solar cells. Yes AI, #EVs, drones, VR, AR, and IoT are diffusing and thus an analysis in 10 years might come to different conclusions, but for 2010s, there was little to commercialize. #innovation #ipo #ipos #venturecapital #vcs #vc https://lnkd.in/gThUWFR

***

***

UPDATE: https://www.seedtable.com/startups-deeptech

***

COMMENTS APPRECIATED

Thank You

***

PODCAST: Healthcare Stocks, Investing & IPOs?

By Eric Bricker MD

Healthcare Stock and IPO Investing Can Be Confusing. The Story of Privia Health is a Good Case Study in Understanding the Underlying Economics in Healthcare Investing:

CITE: https://www.r2library.com/Resource/Title/0826102549

***

***
YOUR COMMENTS ARE APPRECIATED.

Thank You

Comprehensive Financial Planning Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners™

ORDER: https://www.routledge.com/Comprehensive-Financial-Planning-Strategies-for-Doctors-and-Advisors-Best/Marcinko-Hetico/p/book/9781482240283

***

PODCAST: Microsoft Buys Nuance; IPOs

By THCB

Today on Health in 2 Point 00, Jess DaMassa claims to be blameless for the drama between Jonathan Bush and Glen Tullman. On Episode 198, we talk about Microsoft buying Nuance for $16 billion and $3 billion in debt – is Microsoft taking over healthcare, and is this going to slow Nuance down?

IPOs

Cohere Health raises $36 million in a Series B, working on improving prior authorizations between health plans and providers. We wrap up with a lightning round of IPO rumors regarding Privia Health, VillageMD, and Bright Health.

MORE: https://thehealthcareblog.com/blog/2021/04/13/healthin2point00-episode-198-microsoft-buys-nuance-lots-of-ipo-rumors/

Your thoughts are appreciated.

THANK YOU

***

Forget IPOs

Forget IPOs?

Initial Coin Offerings are how blockchain startups now offer investors a return,

but they’re certainly no less risky than Wall Street.

 *** 

 ***

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Comprehensive Financial Planning Strategies for Doctors and Advisors: Best Practices from Leading Consultants and Certified Medical Planners™

***

2014 – A Near Record Year for IPOs

Join Our Mailing List

A 2014 Wrap-Up 

[By Inside the Ticker]

***

1

***

2

***

3

***

More:

Assessment

Channel Surfing the ME-P

Have you visited our other topic channels? Established to facilitate idea exchange and link our community together, the value of these topics is dependent upon your input. Please take a minute to visit. And, to prevent that annoying spam, we ask that you register. It is fast, free and secure.

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Financial Planning MDs 2015

Comprehensive Financial Planning Strategies for Doctors and Advisors: Best Practices from Leading Consultants

***

A Look at Some Famous IPOs [Including WebMD]

Join Our Mailing List

Where Are They Now?

Assessment

With all the FB hoopla recently, we thought it would be fun to look at some other famous IPOs.

Link: http://marketday.msnbc.msn.com/_news/2012/05/23/11830823-facebooks-dream-ipo-is-starting-to-look-like-a-nightmare?lite

Channel Surfing the ME-P

Have you visited our other topic channels? Established to facilitate idea exchange and link our community together, the value of these topics is dependent upon your input. Please take a minute to visit. And, to prevent that annoying spam, we ask that you register. It is fast, free and secure.

Conclusion

Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.

Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com

OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:

Product DetailsProduct DetailsProduct Details

Product Details  Product Details

Product Details